Patents by Inventor Philippe Genne

Philippe Genne has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical compositions containing cinchonine dichlorhydrate
    Patent number: 6528524
    Abstract: The invention relates to pharmaceutical compositions containing cinchonine dihydrochloride as active ingredient with a purity of at least 95%. The invention also relates to a process for preparing cinchonine dihydrochloride from cinchonine and the use of pharmaceutical compositions containing cinchonine dihydrochloride for treating multiple drug resistance.
    Type: Grant
    Filed: February 23, 2000
    Date of Patent: March 4, 2003
    Assignee: Debiopharm SA
    Inventors: Philippe Genne, Houssam Ibrahim
  • PHARMACEUTICAL COMPOSITIONS CONTAINING CINCHONINE DICHLORHYDRATE
    Publication number: 20020091136
    Abstract: The invention relates to pharmaceutical compositions containing cinchonine dihydrochloride as active ingredient with a purity of at least 95%. The invention also relates to a process for preparing cinchonine dihydrochloride from cinchonine and the use of pharmaceutical compositions containing cinchonine dihydrochloride for treating multiple drug resistance.
    Type: Application
    Filed: February 23, 2000
    Publication date: July 11, 2002
    Inventors: PHILIPPE GENNE, HOUSSAM IBRAHIM
  • Therapeutic agents for the treatment of multiple drug resistance of cancers
    Patent number: 5635515
    Abstract: Cinchonine, dihydrocinchonine or hydroquinidine are used as multidrug resistance inhibiting substance in the treatment of cancerous tumors by the use of cytotoxic agents. Particularly, cinchonine, dihydrocinchonine or hydroquinidine are used in the preparation of pharmaceutical compositions used in the treatment of cancerous tumors developing the phenomenon of multidrug resistance. Application to the treatment of human cancers.
    Type: Grant
    Filed: March 3, 1995
    Date of Patent: June 3, 1997
    Assignee: Debiopharm S.A.
    Inventors: Bruno Chauffert, Philippe Genne, Gilles Gutierrez, Rolland-Yves Mauvernay